At a recent event organized by that consortium, the New Jersey Alliance for Clinical and Translational Science(NJACTS), leaders from academia, healthcare, government and the pharmaceutical industry discussed the future of scientific and clinical trial innovation in the state. These new innovations will result from a $33-million grant from the National Institutes of Health (NIH). To read the full story.
Recent Posts
- Rutgers deans: We train advanced practice nurses for N.J. Our laws send them elsewhere.
- Push for raw milk intensifies across the US, despite illness outbreaks and scientists’ warnings.
- Princeton undergraduates build real-world skills through community health micro-internships.
- Join Clinical Trials Day at Rutgers on 5/20
- NJ ACTS Success Story – The Kiosk Project
Categories
- Community (2,492)
- Covid (1,001)
- CTO Events (6)
- News (3,164)
- Pilots (21)